Author

Alison Yu

Rowan UniversityORCID 0009-0000-6674-9397Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Alison Yu1 paper

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Research Focus:protein folding & dynamics· 1 Assay:proteomics· 1

Frequent Co-Authors

Alexander M. PriceiD· 1 shared Bamidele Toheeb Towolawi· 1 shared Claire M O'Brien· 1 shared Clayton J. OtteriD· 1 shared Daniel T. ClaiborneiD· 1 shared Lorenzo SerraiD· 1 shared Molly R. PattersoniD· 1 shared Reyes Acosta· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

Alexander M. PriceORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

MicrobiologybioRxivPreprintJun 27, 2026

Inhibition of RNA splicing is a novel therapeutic strategy for disruption of nuclear replicating viruses

Lorenzo Serra, Claire M O'Brien, Molly R. Patterson…·Alexander M. Price

This study shows that inhibiting RNA splicing reduces viral replication in splicing-dependent viruses like adenovirus, HSV-1, and influenza A, suggesting a new antiviral strategy.

DOI 10.64898/2026.06.26.734849

humanbulk RNA-seq

𝕏 PostBluesky

BiochemistryJournal of Biological ChemistryPeer-reviewedDec 9, 2025

Targeting the Protein-Protein Interaction Between the CDC37 Co-Chaperone and Client Kinases by an Allosteric RAF Dimer Breaker

Alison Yu, Shrhea Banerjee, Sravani Malasani…·Zhihong Wang

This study investigates Braftide's dual effect on RAF dimer disruption and CDC37-client kinase interaction, showing proteasomal degradation and therapeutic potential.

2 citations

humanproteomics

𝕏 PostBluesky